Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People's Republic of China. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia (AGA) and acne vulgaris, which is in phase III clinical trial; and GT20029, a topical AR-PROTAC compoun… Read more
Market Cap & Net Worth: Kintor Pharmaceutical Limited (KNTPF)
Kintor Pharmaceutical Limited (PINK:KNTPF) has a market capitalization of $91.59 Million ($91.59 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #19313 globally and #7115 in its home market, demonstrating a 36.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kintor Pharmaceutical Limited's stock price $0.21 by its total outstanding shares 438416420 (438.42 Million).
Kintor Pharmaceutical Limited Market Cap History: 2020 to 2025
Kintor Pharmaceutical Limited's market capitalization history from 2020 to 2025. Data shows change from $540.30 Million to $91.59 Million (-33.72% CAGR).
Kintor Pharmaceutical Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kintor Pharmaceutical Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.03x
Kintor Pharmaceutical Limited's market cap is 14.03 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $4.82 Billion | $34.23 Million | -$842.10 Million | 140.88x | N/A |
| 2024 | $70.15 Million | $5.00 Million | -$155.29 Million | 14.03x | N/A |
Competitor Companies of KNTPF by Market Capitalization
Companies near Kintor Pharmaceutical Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Kintor Pharmaceutical Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Kintor Pharmaceutical Limited Historical Marketcap From 2020 to 2025
Between 2020 and today, Kintor Pharmaceutical Limited's market cap moved from $540.30 Million to $ 91.59 Million, with a yearly change of -33.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $91.59 Million | +30.56% |
| 2024 | $70.15 Million | -7.03% |
| 2023 | $75.45 Million | -86.12% |
| 2022 | $543.64 Million | -88.73% |
| 2021 | $4.82 Billion | +792.57% |
| 2020 | $540.30 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Kintor Pharmaceutical Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $91.59 Million USD |
| MoneyControl | $91.59 Million USD |
| MarketWatch | $91.59 Million USD |
| marketcap.company | $91.59 Million USD |
| Reuters | $91.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.